Diffusion Pharmaceuticals Inc.

• locale

  United States

• market

  STOCKS

• industry

  Biotechnology

• website

  www.diffusionpharma.com

• ipo date

  May 23, 2008

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, V...Show More

*Estimate based on analyst consensus